Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter April 24, 2015

Interpretation of the Chinese expert consensus: Recommendations for diagnosis and treatment of asymptomatic hyperuricemia complicated with cardiovascular diseases

  • Li-xin Guo EMAIL logo

Abstract

Hyperuricemia (HUA) is a metabolic disease with close links to a number of cardiovascular diseases. The present study interpreted the Chinese expert consensus recommendations for the diagnosis and treatment of asymptomatic HUA complicated with cardiovascular diseases and illustrated the risk factors for HUA, diagnostic criteria, epidemiology of the causal relationship between HUA and cardiovascular diseases, clinical studies and recommendations on medical treatment of asymptomatic HUA.

References

1. Guides and Consensus for Prevention and Treatment of Cardiovascular Diseases, China: People’s Medical Publishing House, ISBN978- 7 -117-12128 - 6 /R. 12129. 2013; p. 198-213.Search in Google Scholar

2. Fang WG, Huang XM, Wang Y, Zhu WG, Bie ZX, Chen JL, et al. A cross-sectional study of hyperuricemia in state-employees in Beijing: Prevalence and risk factors. Zhonghua Yi Xue Za Zhi 2006;86:1764-8.Search in Google Scholar

3. Zhang XS, Yu WG, Yu LX, Zhang LY, Yu Y. The epidemiology investigation of hyperuricemia and gout in Shandong province Haiyang city community’s resident. Chin J Gen Pract 2006;5:216-9.Search in Google Scholar

4. Gu P. Health examination people’s hyperuricemia cases in Guangzhou city and the related disease analysis. China Trop Med 2006;6:1082-4.Search in Google Scholar

5. Yu JW, Lu JB, Zhang XJ, Yang YB, Liu BL, Yu SY, et al. The analysis of blood uric acid and the indications associated with hyperuricemia in 13324 Foshan’s inhabitants. Chin J Invest Tradit West Nephrol 2005;7:401-3.Search in Google Scholar

6. Meisinger C, Koenig W, Baumert J, Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: The MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008;28:1186-92.10.1161/ATVBAHA.107.160184Search in Google Scholar PubMed

7. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause cardiovascular, and ischemic stroke mortality: A Chinese cohort study. Arthritis Rheum 2009;61:225-32.10.1002/art.24164Search in Google Scholar PubMed

8. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96.10.1002/art.22014Search in Google Scholar PubMed

9. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008;19:2407-13.10.1681/ASN.2008010080Search in Google Scholar PubMed PubMed Central

10. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol 2007;39:1227-33.10.1007/s11255-007-9253-3Search in Google Scholar PubMed

Published Online: 2015-4-24
Published in Print: 2014-6-1

© 2015

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.4103/2224-4018.135617/html
Scroll to top button